Melissa B. Epperly, Director at Roivant Sciences Ltd. (ROIV), sold 41,861 shares at $28.68 ($1.2M) on 2026-03-16, disclosed to the SEC on 2026-03-18.
Open-market sale of $1.2M ROIV by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ROIV | SELL | 2026-07-01 | $610K | — | Filing → |
| ZNTL | SELL | 2024-02-12 | $29K | — | Filing → |
| ZNTL | SELL | 2024-02-05 | $200K | — | Filing → |